Preoperative statin and diuretic use influence the presentation of patients undergoing carotid endarterectomy: Results of a large single-institution case-control study

Journal of Vascular Surgery

Volumn 45, Issue 2, 2007, Pages 298-303

  Brooke, Benjamin S ^a   McGirt, Matthew J ^a   Woodworth, Graeme F ^a   Chang, David C ^a   Roseborough, Glen S ^a   Freischlag, Julie A ^a   Perler, Bruce A ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CAROTID ARTERY DISEASE; CAROTID ARTERY OBSTRUCTION; CAROTID ENDARTERECTOMY; CASE CONTROL STUDY; CEREBROVASCULAR DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; HUMAN; HYPERLIPIDEMIA; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEX RATIO; STROKE; TRANSIENT ISCHEMIC ATTACK; TREATMENT OUTCOME;

AGED; BALTIMORE; CAROTID STENOSIS; CASE-CONTROL STUDIES; CEREBROVASCULAR ACCIDENT; DIURETICS; ENDARTERECTOMY, CAROTID; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; ISCHEMIC ATTACK, TRANSIENT; LOGISTIC MODELS; MALE; ODDS RATIO; PREOPERATIVE CARE; RETROSPECTIVE STUDIES; RISK FACTORS; ROC CURVE; TREATMENT OUTCOME;

EID: 33846419493     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvs.2006.11.013     Document Type: Article

References (30)

1. Chambers B.R., You R.X., and Donnan G.A. Carotid endarterectomy for asymptomatic carotid stenosis. Cochrane Database Syst Rev 2 (2000) CD001923
2. Rothwell P.M., Eliasziw M., Gutnikov S.A., Fox A.J., Taylor D.W., Mayberg M.R., et al. Analysis of pooled data from the randomized controlled trials of endarterectomy for symptomatic carotid stenosis. Lancet 361 (2003) 107-116
3. North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med 325 (1991) 445-453
4. Executive Committee for the Asymptomatic Carotid Arteriosclerosis Study. Endarterectomy for asymptomatic carotid artery stenosis. JAMA 273 (1995) 1421-1428
5. Halliday A., Mansfield A., Marro J., Peto C., Peto R., Potter J., et al. Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomized controlled trial. Lancet 363 (2004) 1491-1502
6. Staessen J.A., Gasowski J., Wang J.G., Thijs L., Den Hond E., Boissel J.P., et al. Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials. Lancet 355 (2000) 865-872
7. Fisher M., Paganini-Hill A., Martin A., Cosgrove M., Toole J.F., Barnett H.J., et al. Carotid plaque pathology: thrombosis, ulceration, and stroke pathogenesis. Stroke 36 (2005) 253-257
8. Golledge J., Cuming R., Ellis M., Davies A.H., and Greenhalgh R.M. Carotid plaque characteristics and presenting symptoms. Br J Surg 84 (1997) 1697-1701
9. Messerli F.H., Grossman E., and Lever A.F. Do thiazide diuretics confer specific protection against strokes?. Arch Intern Med 163 (2003) 2557-2560
10. Klungel O.H., Heckbert S.R., Longstreth Jr. W.T., Furberg C.D., Kaplan R.C., Smith N.L., et al. Antihypertensive drug therapies and the risk of ischemic stroke. Arch Intern Med 161 (2001) 37-43
11. Amarenco P., Labreuche J., Lavallee P., and Touboul P.J. Statins in stroke prevention and carotid atherosclerosis: systematic review and up-to-date meta-analysis. Stroke 35 (2004) 2902-2909
12. Vaughan C.J. Prevention of stroke and dementia with statins: effects beyond lipid lowering. Am J Cardiol 91 Suppl (2003) 23B-29B
13. Golleredge J., Greenhalgh R.M., and Davies A.H. The symptomatic carotid plaque. Stroke 31 (2000) 774-781
14. Adamina M., Guller U., Weber W.P., and Oertli D. Propensity scores and the surgeon. Br J Surg 93 (2006) 389-394
15. Sitzer M., Muller W., Siebler M., Hort W., Kniemeyer H.W., Jancke L., et al. Plaque ulceration and lumen thrombus are the main sources of cerebral microemboli in high-grade internal carotid artery stenosis. Stroke 26 (1995) 1231-1233
16. Avril G., Batt M., Guidoin R., Marois M., Hassen-Khodja R., Daune B., et al. Carotid endarterectomy plaques: correlations of clinical and anatomic findings. Ann Vasc Surg 5 (1991) 50-54
17. Carr S., Farb A., Pearce W.H., Virmini R., and Yao J.S.T. Atherosclerotic plaque rupture in symptomatic carotid artery stenosis. J Vasc Surg 23 (1996) 755-766
18. Jander S., Sitzer M., Schumann R., Schroeter M., Siebler M., Steinmetz H., et al. Inflammation in high-grade carotid stenosis: a possible role for macrophages and T cells in plaque destabilization. Stroke 29 (1998) 1625-1630
19. Gronholt M.L.M. Ultrasound and lipoproteins as predictors of lipid-rich, rupture-prone plaques in the carotid artery. Arterioscler Thromb Vasc Biol 19 (1999) 2-13
20. Heart Protection Study Collaborative Group. The MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high risk individuals: a randomized placebo-controlled trial. Lancet 360 (2002) 7-22
21. Schonbeck U., and Libby P. Inflammation, immunity, and HMG-CoA reductase inhibitors: statins as anti-inflammatory agents?. Circulation 109 Suppl 2 (2004) II18-II26
22. Crisby M., Nordin-Fredriksson G., Shah P.K., Yano J., Zhu J., and Nilsson J. Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques: implications for plaque stabilization. Circulation 103 (2001) 926-933
23. Molloy K.J., Thompson M.M., Schwalbe E.C., Bell P.R.F., Naylor R., and Loftus I.M. Comparison of levels of matrix metalloproteinases, tissue inhibitor of metalloproteinases, interleukins, and tissue necrosis factor in carotid endarterectomy specimens from patients on versus not on statins preoperatively. Am J Cardiol 94 (2004) 144-146
24. McGirt M.J., Perler B.A., Brooke B.S., Coon A.L., Jain S., Buck D., et al. 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors reduce the risk of perioperative stroke and mortality after carotid endarterectomy. J Vasc Surg 42 (2005) 829-836
25. Kennedy J., Quan H., Buchan A.M., Ghali W., and Feasby T.F. Statins are associated with better outcomes after carotid endarterectomy in symptomatic patients. Stroke 36 (2005) 2072-2076
26. PROGRESS Collaborative Group. Randomized trial of a perindopril-based blood pressure lowering regimen among 6105 individuals with previous stroke or transient ischemic attack. Lancet 358 (2001) 1033-1041
27. Medical Research Council Working Party. MRC trial of treatment of mild hypertension: principal results. Br Med J (Clin Res Ed) 291 (1985) 97-104
28. Psaty B.M., Smith N.L., Siscovick D.S., Koepsell T.D., Weiss N.S., Heckbert S.R., et al. Health outcomes associated with antihypertensive therapies used as first line agents: systematic review and meta-analysis. JAMA 277 (1997) 739-745
29. Fernandez L., Spencer D., and Kaczmar T. Angiotensin II decreases mortality rate in gerbils with unilateral carotid ligation. Stroke 17 (1986) 82-85
30. Klungel O.H., Martens E.P., Psaty B.M., Grobbee D.E., Sullivan S.D., Stricker B.H., et al. Methods to assess intended effects of drug treatment in observational studies are reviewed. J Clin Epidemiol 57 (2004) 1223-1231